iShares 20+ Year Treasury Bond ETF (TLT) NASDAQ
85.65
+0.18(+0.21%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
85.65
+0.18(+0.21%)
Currency In USD
| Previous Close | 85.47 |
| Open | 85.8 |
| Day High | 85.82 |
| Day Low | 85.5 |
| 52-Week High | 92.19 |
| 52-Week Low | 82.77 |
| Volume | 20.26M |
| Average Volume | 31.55M |
| Market Cap | 42.87B |
| PE | -6.81 |
| EPS | -12.59 |
| Moving Average 50 Days | 85.86 |
| Moving Average 200 Days | 87.98 |
| Change | 0.18 |
Theralase(R) Announces Brokered LIFE Financing to Further Advance its Phase II Non-Muscle Invasive Bladder Cancer Clinical Study
Newsfile
Nov 24, 2025 12:00 PM GMT
Toronto, Ontario--(Newsfile Corp. - November 24, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light, radiation, sound and drug-activated therapeuti